Literature DB >> 34220010

Antinuclear Antibody Profiling in Patients of a Tertiary Care Centre in Central India.

Prishni Gupta1, Pratishtha Agrawal1, Neha Rani Verma1, Seema Shah1, Suprava Patel1, Rachita Nanda1, Eli Mohapatra1.   

Abstract

The incidence of autoimmune disorders that includes the connective tissue diseases has seen a rise in India in recent times. Antinuclear antibodies, the telltale sign of systemic autoimmune response, thus can be used as a screening tool and also to support the diagnosis of systemic autoimmune disease. The present retrospective cross- sectional analysis aimed to study the antinuclear antibodies profile (patterns and specific antibody reactivity) amongst suspected cases of auto-immune disorders at a tertiary care teaching hospital. The study retrieved and reviewed reports of 644 patients sent for ANA testing by indirect immunofluorescence assay over a period of 1 year by different specialty departments. Positive samples were further processed for anti-ds-DNA antibody and antibodies to extractable nuclear antigen. Data collected was statistically analysed. ANA pattern positivity was observed in 31% of cases and a positive antibody reactivity was seen in 66% of them. Female predominance (82%) was noted in both pattern positivity and antibody reactivity. High levels of pattern positivity and antibody reactivity was found in the young adults (45.9%). Amongst the ANA patterns, the nuclear homogenous pattern was found the commonest. The common antibodies associated with this pattern were anti-dsDNA and U1 Sm/RNP antibodies. A stronger fluorescence intensity on initial screening showed a higher confirmation rate for specific antibodies on immunoassay. High occurrence of positive ANA patterns in autoimmune disorders suggests its utilization as a screening tool for them and would also play an adjuvant to the diagnosis. Early knowledge about future autoimmunity will earn better prognostic achievements through better treatment interventions. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  Anti dsDNA; Antibody reactivity; Immunoassay; Immunofluorescence assay

Year:  2020        PMID: 34220010      PMCID: PMC8215003          DOI: 10.1007/s12291-020-00925-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  20 in total

Review 1.  From ANA to ENA: how to proceed?

Authors:  J G M C Damoiseaux; J W Cohen Tervaert
Journal:  Autoimmun Rev       Date:  2005-06-13       Impact factor: 9.754

2.  Antinuclear antibody positive autoimmune disorders in North India: an appraisal.

Authors:  Ranjana Walker Minz; Yashwant Kumar; Shashi Anand; Surjit Singh; Pradeep Bamberi; Subhash Verma; Shobha Shegal
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

Review 3.  Updated assessment of the prevalence, spectrum and case definition of autoimmune disease.

Authors:  Scott M Hayter; Matthew C Cook
Journal:  Autoimmun Rev       Date:  2012-02-23       Impact factor: 9.754

4.  Serum antinuclear antibody in adult Thais.

Authors:  Chanwit Prapinjumrune; Chalakorn Prucktrakul; Trakarn Sooktonglarng; Kobkan Thongprasom
Journal:  Gerodontology       Date:  2016-05-12       Impact factor: 2.980

5.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Authors:  Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2012-07

6.  Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.

Authors:  Wendy Sebastian; Atanu Roy; Usha Kini; Shalini Mullick
Journal:  Indian J Pathol Microbiol       Date:  2010 Jul-Sep       Impact factor: 0.740

7.  Age and sex associations of 40 autoimmune diseases.

Authors:  P B Beeson
Journal:  Am J Med       Date:  1994-05       Impact factor: 4.965

8.  Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.

Authors:  Christine G Parks; Frederick W Miller; Minoru Satoh; Edward K L Chan; Zhanna Andrushchenko; Linda S Birnbaum; Todd A Jusko; Grace E Kissling; Mehul D Patel; Kathryn M Rose; Clarice Weinberg; Darryl C Zeldin; Dale P Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-01       Impact factor: 4.254

9.  Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.

Authors:  Manas K Akmatov; Nadja Röber; Wolfgang Ahrens; Dieter Flesch-Janys; Julia Fricke; Halina Greiser; Kathrin Günther; Rudolf Kaaks; Yvonne Kemmling; Bastian Krone; Jakob Linseisen; Christa Meisinger; Susanne Moebus; Nadia Obi; Carlos A Guzman; Karsten Conrad; Frank Pessler
Journal:  Arthritis Res Ther       Date:  2017-06-06       Impact factor: 5.156

Review 10.  The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.

Authors:  S Chandrashekara
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.